Is it prime time to consider a clinical trial of doxycycline for the management of COVID-19?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is it prime time to consider a clinical trial of doxycycline for the management of COVID-19?

Published:2020-12-03 Issue: Volume: Page:postgradmedj-2020-139358
ISSN:0032-5473
Container-title:Postgraduate Medical Journal
language:en
Short-container-title:Postgrad Med J

Author:

Milionis Haralampos,Kostikas Konstantinos^ORCID

Publisher

BMJ

Subject

General Medicine

Reference5 articles.

1. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;Gautret;Int J Antimicrob Agents,2020

2. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

3. Effects of levofloxacin and doxycycline on interleukin-6 production of Chlamydia trachomatis-infected human synovial fibroblasts;Ikeda-Dantsuji;Chemotherapy,2007

4. Dengue patients treated with doxycycline showed lower mortality associated to a reduction in IL-6 and TNF levels;Fredeking;Recent Pat Antiinfect Drug Discov,2015

5. The Recovery Collaborative Group . Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 2020:NEJMoa2022926. doi:10.1056/NEJMoa2022926

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential drug development and therapeutic approaches for clinical intervention in COVID-19;Bioorganic Chemistry;2021-09

2. Molecular Mechanisms of Melatonin-Mediated Cell Protection and Signaling in Health and Disease;Pharmaceutics;2021-01-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3